Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Clinical Subtype | Transcriptional Subtype | Small Molecule | Antibody | Perturbagen Target | Perturbagen Class | Perturbagen Concentration | Perturbagen Conc Unit | Biological Replicate ID | Relative Cell Count | Normalized Growth Rate Inhibition Value | Nominal Division Rate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0274 | uM | 7805.018 | 0.9659 | 0.9403 | 1.1451 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.137 | uM | 7805.018 | 1.0849 | 1.1475 | 1.1451 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.685 | uM | 7805.018 | 1.0499 | 1.0869 | 1.1451 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 9210.026 | 1.0106 | 1.0232 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 9210.026 | 1.0431 | 1.0949 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0000438 | uM | 9210.026 | 1.0583 | 1.1285 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.000219 | uM | 9210.026 | 1.0247 | 1.0543 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0011 | uM | 9210.026 | 1.0323 | 1.0710 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.00548 | uM | 9210.026 | 0.9983 | 0.9963 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.0274 | uM | 9210.026 | 1.0090 | 1.0198 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.137 | uM | 9210.026 | 1.0611 | 1.1346 | 0.9102 | |
| CAMA-1 | HR+ | Luminal | Cetuximab | EGFR | ErbB | 0.685 | uM | 9210.026 | 1.0218 | 1.0481 | 0.9102 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7429.102 | 1.0214 | 1.0174 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 7429.102 | 1.0080 | 1.0065 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.0000438 | uM | 7429.102 | 1.0073 | 1.0060 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.000219 | uM | 7429.102 | 1.0322 | 1.0262 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.0011 | uM | 7429.102 | 1.0177 | 1.0145 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00548 | uM | 7429.102 | 0.9608 | 0.9674 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.0274 | uM | 7429.102 | 0.9709 | 0.9759 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.137 | uM | 7429.102 | 0.9736 | 0.9782 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.685 | uM | 7429.102 | 0.9635 | 0.9697 | 2.4347 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000175 | uM | 7807.042 | 1.0293 | 1.0287 | 2.0250 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.00000877 | uM | 7807.042 | 1.0479 | 1.0468 | 2.0250 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.0000438 | uM | 7807.042 | 1.0625 | 1.0608 | 2.0250 | |
| HBL-100 | Unknown | Unknown | Cetuximab | EGFR | ErbB | 0.000219 | uM | 7807.042 | 1.0538 | 1.0524 | 2.0250 |